Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The influence of SARS-CoV-2 infection on expression of drug-metabolizing enzymes and transporters in a hACE2 murine model. | Pharmacol Res Perspect | 2023 | 37133236 | PubTator, text mining | PubMed |
| Metformin: update on mechanisms of action and repurposing potential. | Nat Rev Endocrinol | 2023 | 37130947 | PubTator, text mining | PubMed |
| Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid. | Front Pharmacol | 2023 | 37124197 | PubTator, text mining | PubMed |
| Overcoming Biological Barriers: Importance of Membrane Transporters in Homeostasis, Disease and Disease Treatment. | Int J Mol Sci | 2023 | 37108379 | PubTator, text mining | PubMed |
| Integrative genetic analysis identifies FLVCR1 as a plasma-membrane choline transporter in mammals. | Cell Metab | 2023 | 37100056 | PubTator, text mining | PubMed |
| Prediction for Plasma Trough Concentration and Optimal Dosing of Imatinib under Multiple Clinical Situations Using Physiologically Based Pharmacokinetic Modeling. | ACS Omega | 2023 | 37091368 | PubTator, text mining | PubMed |
| Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients. | World J Gastroenterol | 2023 | 37077515 | PubTator, text mining | PubMed |
| LC-MS/MS method for the quantitation of OCT1 biomarker isobutyrylcarnitine in human plasma with clinical sample analysis. | Bioanalysis | 2023 | 37073675 | PubTator, text mining | PubMed |
| Genetic variation in organic cation transporters and considerations in drug development. | Expert Opin Drug Metab Toxicol | 2023 | 37070463 | PubTator, text mining | PubMed |
| Near-infrared fluorescence imaging of hepatocellular carcinoma cells regulated by β-catenin signaling pathway. | Front Oncol | 2023 | 37064109 | PubTator, text mining | PubMed |
| Association of SLC11A1 polymorphisms with anthropometric and biochemical parameters describing Type 2 Diabetes Mellitus. | Sci Rep | 2023 | 37062790 | PubTator, text mining | PubMed |
| Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies. | J Clin Pharmacol | 2023 | 37043676 | PubTator, text mining | PubMed |
| Novel Explanted Human Liver Model to Assess Hepatic Extraction, Biliary Excretion and Transporter Function. | Clin Pharmacol Ther | 2023 | 37042227 | PubTator, text mining | PubMed |
| Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine. | ACS Omega | 2023 | 37033868 | PubTator, text mining | PubMed |
| Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease. | Front Immunol | 2023 | 37020540 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Pseudo-AKI associated with targeted anti-cancer agents-the truth is in the eye of the filtration marker. | Clin Kidney J | 2023 | 37007700 | PubTator, text mining | PubMed |
| Characterization of ligand-induced thermal stability of the human organic cation transporter 2 (OCT2). | Front Pharmacol | 2023 | 37007010 | PubTator, text mining | PubMed |
| The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations. | Mol Cancer Ther | 2023 | 36999986 | PubTator, text mining | PubMed |
| Change of metformin concentrations in the liver as a pharmacological target site of metformin after long-term combined treatment with ginseng berry extract. | Front Pharmacol | 2023 | 36998615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=17